LRCX

Lam Research

$335.43

-3.08%
Jul 15, 2026
Bobby Quantitative Model
Lam Research is a leading manufacturer of semiconductor wafer fabrication equipment, specializing in deposition and etch processes essential for chip production. It holds the top market share in etch and the second-largest share in deposition, serving top-tier customers like TSMC, Samsung, Intel, and Micron. The stock is currently driven by the AI infrastructure build-out, which is fueling demand for advanced memory and logic chips, while recent news highlights both record revenue and concerns about overvaluation in the semiconductor space.

People also watch

Nvidia

Nvidia

NVDA

Analysis
Broadcom

Broadcom

AVGO

Analysis
Micron Technology

Micron Technology

MU

Analysis
AMD

AMD

AMD

Analysis
Intel

Intel

INTC

Analysis

BobbyInvestment Opinion: Should I buy LRCX Today?

Rating: Buy. Lam Research is a high-quality growth stock benefiting from secular AI demand, with strong revenue growth, high margins, and a dominant market position. The analyst consensus is Buy, and the average target price implies upside from current levels, though specific targets are not provided.

Supporting Evidence: Revenue grew 22.1% YoY to $5.34 billion, net margin is 29.8%, operating margin improved to 33.9%, and free cash flow is $6.66 billion. The trailing P/E of 23.3x is above the industry average of ~20x, but the PEG ratio of 0.54 suggests the stock is undervalued relative to its growth rate. ROE of 54.3% indicates efficient capital use. The forward P/E of 43.5x reflects high growth expectations, but the company's dominant position and AI tailwinds support this premium.

Risks & Conditions: The biggest risks are a slowdown in AI spending, cyclical downturn, and valuation compression. This Buy rating would be downgraded to Hold if revenue growth decelerates below 15% or if the forward P/E expands above 50x. It would be upgraded to Strong Buy if the PEG ratio falls below 0.4 or if the company announces a major new customer. Overall, Lam Research is fairly valued relative to its growth prospects, but investors should be prepared for volatility.

Sign up to view all

LRCX 12-Month Price Forecast

Lam Research is well-positioned to benefit from the multi-year AI infrastructure build-out, with strong fundamental momentum and a dominant market position. The current valuation is elevated but justified by the growth trajectory and profitability. The base case of moderate growth is most likely, but the bull case has a meaningful probability given the AI tailwinds. Key factors to watch are revenue growth sustainability and margin trends. The stance is bullish with medium confidence due to valuation risks and cyclicality. An upgrade would require sustained revenue growth above 25% and margin expansion; a downgrade would occur if growth decelerates below 15% or if geopolitical risks materialize.

Historical Price
Current Price $335.43
Average Target $355.00
High Target $450.00
Low Target $250.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $436.06 and implied upside of +30.0% versus the current price.

Average Target

$436.06

10 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

10

covering this stock

Price Range

$268 - $436

Analyst target range

Buy
3 (30%)
Hold
5 (50%)
Sell
2 (20%)

Lam Research is covered by 10 analysts, with a consensus leaning bullish. The average EPS estimate for the current fiscal year is $13.22, with a range of $11.79 to $15.24. Revenue estimates average $44.93 billion, implying continued strong growth. While specific price targets are not provided, the consensus recommendation based on recent ratings is a Buy (with firms like Needham, UBS, Goldman Sachs, and Stifel reiterating Buy ratings). The average target price is not available, but the high EPS estimate of $15.24 suggests optimism about margin expansion and revenue growth. Recent ratings have been stable, with no downgrades in the past six months, indicating analyst confidence. The spread between low and high EPS estimates ($11.79 to $15.24) is moderate, reflecting some uncertainty about the pace of AI-driven demand but overall conviction in the growth story.

Drowning in data?

Find the real signal!

Bulls vs Bears: LRCX Investment Factors

Lam Research presents a compelling bull case driven by its dominant market position in etch and deposition, accelerating revenue growth fueled by AI infrastructure demand, and strong profitability with a net margin of 29.8%. The company's robust balance sheet and free cash flow of $6.66 billion provide financial flexibility. However, the bear case highlights elevated valuation with a forward P/E of 43.5x, cyclical industry risks, and high beta of 1.805 that amplifies downside. The single most important tension is whether the AI-driven demand cycle can sustain the growth trajectory needed to justify the current valuation. If revenue growth continues to accelerate and margins expand, the stock could re-rate higher; conversely, any slowdown in AI spending or a cyclical downturn could lead to significant multiple compression. Currently, the bull case has stronger evidence given the strong fundamental momentum and analyst consensus, but investors should monitor valuation closely.

Bullish

  • Dominant Market Position in Etch and Deposition: Lam Research holds the top market share in etch and the second-largest share in deposition, serving key customers like TSMC, Samsung, Intel, and Micron. This leadership provides pricing power and long-term contracts, underpinning revenue stability and growth.
  • Accelerating Revenue Growth: Revenue grew 22.1% YoY to $5.34 billion in Q2 FY2026, marking an acceleration from the prior year's Q2 revenue of $4.38 billion. This growth is driven by AI infrastructure demand, with sequential increases over the past four quarters.
  • High Profitability and Strong Margins: Net margin stands at 29.8% and operating margin improved to 33.9% in Q2 FY2026 from 30.5% a year ago. ROE is robust at 54.3%, indicating efficient capital use and strong earnings generation.
  • Strong Balance Sheet and Cash Flow: Debt-to-equity is low at 0.48, current ratio is 2.21, and free cash flow for the trailing twelve months is $6.66 billion. This provides ample liquidity for R&D, dividends, and share buybacks, reducing financial risk.

Bearish

  • Elevated Forward P/E Multiple: The forward P/E of 43.5x implies that significant earnings growth is already priced in. If growth disappoints, the stock could face multiple compression, especially given the premium to the industry average trailing P/E of ~20x.
  • Cyclical Semiconductor Industry Risk: The semiconductor industry is historically cyclical, and Lam's revenue is tied to capital expenditure cycles of chipmakers. A downturn in memory demand or a pullback in AI spending could lead to sharp revenue declines.
  • High Beta Amplifies Downside: With a beta of 1.805, the stock is 80.5% more volatile than the market. In a broad market sell-off, Lam could underperform significantly, as seen in the 24.74% max drawdown from its 52-week high.
  • Potential Overvaluation Concerns: Recent news suggests 'sell the news' events and concerns about overvaluation in AI-related sectors. The stock's 1-year gain of 246.7% may have priced in optimistic assumptions, leaving little room for error.

LRCX Technical Analysis

Lam Research is in a strong long-term uptrend, with a 1-year price change of +246.7%. The current price of $350.33 sits at 79.9% of its 52-week range ($90.94 low to $438.50 high), indicating the stock is near the upper end of its range but not at overbought extremes. This positioning suggests sustained momentum but also potential resistance near the high. Over the past 3 months, the stock has gained 32.9%, and over 1 month it has risen 8.9%, showing accelerating short-term momentum. However, the 1-month change of +8.9% is slightly below the 3-month pace, hinting at a possible deceleration. The RSI is not provided, but the relative strength versus the S&P 500 over 1 month is +4.8%, indicating outperformance. The 52-week high of $438.50 acts as key resistance, while the 52-week low of $90.94 is a distant support. A breakout above $438.50 could signal a new leg higher, while a breakdown below the recent low of $326.13 (July 7) would suggest a correction. With a beta of 1.805, the stock is 80.5% more volatile than the market, amplifying both upside and downside moves.

Beta

1.80

1.80x market volatility

Max Drawdown

-24.7%

Largest decline past year

52-Week Range

$91-$439

Price range past year

Annual Return

+231.9%

Cumulative gain past year

PeriodLRCX ReturnS&P 500
1m-13.8%+0.0%
3m+28.5%+7.6%
6m+50.4%+9.1%
1y+231.9%+21.3%
ytd+81.3%+10.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

LRCX Fundamental Analysis

Revenue has been growing strongly, with the most recent quarter (Q2 FY2026, ending Dec 28, 2025) reporting $5.34 billion, up 22.1% year-over-year. This marks an acceleration from the prior year's Q2 revenue of $4.38 billion and continues a multi-quarter trend of sequential growth (Q1 FY2026: $5.32B, Q4 FY2025: $5.17B, Q3 FY2025: $4.72B). The growth is driven by both system sales ($3.36B) and customer support ($1.99B), reflecting broad demand from memory and logic customers. The company is highly profitable, with net income of $1.59 billion in the latest quarter and a net margin of 29.8%. Gross margin has been stable around 49-50% over the past four quarters, while operating margin improved to 33.9% in Q2 FY2026 from 30.5% a year ago. The balance sheet is strong, with a debt-to-equity ratio of 0.48 and a current ratio of 2.21. Free cash flow for the trailing twelve months is $6.66 billion, providing ample liquidity for R&D, dividends, and share buybacks. ROE is robust at 54.3%, indicating efficient capital use.

Quarterly Revenue

$5.3B

2025-12

Revenue YoY Growth

+22.1%

YoY Comparison

Gross Margin

49.6%

Latest Quarter

Free Cash Flow

$6.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Customer Support and Other
System

Open an Account, get $2 TSLA now!

Valuation Analysis: Is LRCX Overvalued?

Since net income is positive, the trailing P/E ratio of 23.3x is the primary valuation metric. The forward P/E of 43.5x implies that the market expects significant earnings growth, which aligns with the company's recent acceleration. The gap between trailing and forward P/E suggests that analysts anticipate a sharp earnings increase in the coming year. Compared to the semiconductor industry, Lam Research's trailing P/E of 23.3x is above the sector average of roughly 20x (based on industry data), representing a 16.5% premium. This premium is justified by Lam's dominant market position in etch and deposition, superior margins (net margin 29% vs. industry average ~20%), and strong growth trajectory. Historically, Lam's trailing P/E has ranged from 8.9x (in 2022) to 34.7x (in late 2025). The current 23.3x is near the middle of this range, suggesting the stock is not excessively overvalued relative to its own history. However, the forward P/E of 43.5x is elevated, implying that much of the expected growth is already priced in.

PE

23.3x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 9x~35x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

19.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: Lam Research's financials are strong, but the high forward P/E of 43.5x implies that much of the expected growth is already priced in. If revenue growth decelerates from the current 22.1% YoY, the stock could face multiple compression. The company's net margin of 29.8% is high, but any margin pressure from rising costs or competitive pricing could impact earnings. Debt-to-equity is low at 0.48, but the reliance on a few large customers (TSMC, Samsung, Intel, Micron) creates revenue concentration risk. Free cash flow of $6.66 billion provides a cushion, but a downturn in chip demand could quickly erode cash generation.

Market & Competitive Risks: The semiconductor equipment industry is cyclical, and Lam's beta of 1.805 indicates high sensitivity to market movements. Valuation compression is a key risk, as the trailing P/E of 23.3x is above the industry average of ~20x, and the forward P/E of 43.5x is even more stretched. Competitive threats from Applied Materials and Tokyo Electron could pressure market share. Recent news highlights 'sell the news' events and overvaluation concerns in AI-related sectors, which could trigger sector rotation. Geopolitical tensions, such as US-China trade restrictions, could limit access to key markets.

Worst-Case Scenario: In a severe downturn, such as a sharp pullback in AI spending or a global recession, Lam's revenue could decline significantly. The 52-week low of $90.94 represents a potential downside of -74% from the current price of $350.33. While this low was set during a prior downturn, a realistic worst-case scenario might see the stock retesting the $200 level (a -43% decline), based on historical drawdowns and analyst low estimates. The max drawdown of -24.74% from the 52-week high of $438.50 to the recent low of $326.13 shows that even in a moderate correction, losses can be substantial.

FAQ

The key risks are: 1) Cyclical downturn in semiconductor industry, which could reduce customer capex and hurt revenue; 2) Valuation risk, as the forward P/E of 43.5x leaves little room for error; 3) Customer concentration, with top customers like TSMC and Samsung accounting for a large portion of revenue; 4) Geopolitical risks, such as US-China trade restrictions that could limit market access. The most severe risk is a sharp pullback in AI spending, which could lead to a 30-40% decline from current levels.

The 12-month outlook is positive, with a base case target range of $330-$380 (probability 50%), assuming moderate AI-driven growth. The bull case (30% probability) targets $400-$450, driven by accelerating demand and margin expansion. The bear case (20% probability) sees a decline to $250-$300 if a cyclical downturn occurs. The most likely scenario is the base case, where revenue grows 15-20% YoY and the stock trades near current levels. Investors should watch for earnings reports and AI capex trends to gauge which scenario unfolds.

Lam Research's trailing P/E of 23.3x is above the semiconductor industry average of ~20x, representing a 16.5% premium. However, the PEG ratio of 0.54 indicates that the stock is undervalued relative to its earnings growth rate. The forward P/E of 43.5x is high, but it reflects expectations of strong earnings growth driven by AI demand. Historically, the trailing P/E has ranged from 8.9x to 34.7x, so the current level is near the middle. Overall, the stock appears fairly valued given its growth prospects, but investors should monitor whether growth materializes to justify the premium.

Lam Research is a good buy for growth investors with a long-term horizon, given its dominant market position and exposure to AI-driven demand. The stock has strong fundamental momentum, with revenue growing 22.1% YoY and net margin of 29.8%. However, the forward P/E of 43.5x is elevated, implying high expectations. The analyst consensus is Buy, and the PEG ratio of 0.54 suggests the stock is undervalued relative to its growth rate. The biggest downside risk is a cyclical downturn or slowdown in AI spending, which could lead to multiple compression. For investors willing to tolerate volatility (beta 1.805), the risk/reward is favorable at current levels.

Lam Research is best suited for long-term investment (3-5 years) given its exposure to secular AI growth and dominant market position. The stock's high beta of 1.805 and recent volatility make it less suitable for short-term trading, though momentum traders may find opportunities. The dividend yield is low at 0.92%, so income-seeking investors should look elsewhere. A minimum holding period of 3 years is recommended to ride out cyclical downturns and benefit from the AI infrastructure build-out. Short-term investors should be prepared for sharp swings, as seen in the 24.74% max drawdown from the 52-week high.